← Search & browse all drugs
ALIMENTARY TRACT AND METABOLISM › DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS › ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS › Synthetic anticholinergic agents in combination with psycholeptics
pipenzolate and psycholeptics
A03CA09
Forms & Strengths
- Combination product: Pipenzolate bromide with psycholeptics (e.g., phenothiazines or benzodiazepines)
- Oral tablets and capsules varying by specific regional manufacturer
Adult Dosing
- Typically 1 tablet or capsule 2 to 3 times daily before meals, adjusted based on individual clinical response and tolerability
- Max daily dose dependent on specific fixed-dose combination product and psycholeptic component limits
Pediatric Dosing
- Safety and efficacy not established in pediatric patients; generally contraindicated or not recommended in children
Indications
- Symptomatic management of hypersecretory, hypermotility gastrointestinal disorders associated with anxiety or emotional stress
- Adjunctive treatment of peptic ulcer disease and irritable bowel syndrome
Mechanism of Action
- Pipenzolate is an anticholinergic/antimuscarinic agent that reduces gastric acid secretion and gastrointestinal motility
- Psycholeptic component acts on the central nervous system to provide sedative, anxiolytic, or tranquilizing effects
Contraindications
- Known hypersensitivity to pipenzolate, anticholinergics, or the co-formulated psycholeptic agent
- Narrow-angle glaucoma
- Gastrointestinal tract obstruction, paralytic ileus, or toxic megacolon
- Uinary tract obstruction or severe prostatic hyperplasia
- Myasthenia gravis
Adverse Reactions
- Dry mouth, blurred vision, and mydriasis
- Constipation and urinary retention
- Tachycardia and palpitations
- Drowsiness, sedation, dizziness, and cognitive impairment due to psycholeptic and anticholinergic load
- Reduced sweating and heat intolerance
Drug Interactions
- Enhanced anticholinergic toxicity when combined with other antimuscarinics, tricyclic antidepressants, or antihistamines
- Additive central nervous system depression with alcohol, opioids, sedatives, and hypnotics
- May alter gastrointestinal absorption of other concurrently administered oral medications due to altered motility
Curated Content: Needs Vetting Before Put to Clinical Use